Identifying groups at high risk for carriage of antibiotic-resistant bacteria.

BACKGROUND No simple, cost-effective methods exist to identify patients at high risk for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization outside intensive care settings. Without such methods, colonized patients are entering hospitals undetected and transmitting these bacteria to other patients. We aimed to develop a highly sensitive, simple-to-administer prediction rule to identify subpopulations of patients at high risk for colonization on hospital admission. METHODS We conducted a prospective cohort study of adult patients admitted to the general medical and surgical wards of a tertiary-care facility. Data were collected using electronic medical records and an investigator-administered questionnaire. Cultures of anterior nares and the perirectal area were also collected within 48 hours of admission. RESULTS Among 699 patients who enrolled in this study, 697 underwent nasal cultures; 555, perirectal cultures; and 553, both. Patient self-report of a hospital admission in the previous year was the most sensitive variable in identifying patients colonized with methicillin-resistant Staphylococcus aureus or with either organism (sensitivity, 76% and 90%, respectively). A prediction rule requiring patients to self-report having received antibiotics and a hospital admission in the previous year would have identified 100% of patients colonized with vancomycin-resistant enterococci. In the high-risk groups defined by the prediction rule, the prevalence of colonization by methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, or either organism were 8.1%, 10.2%, and 15.0%, respectively. CONCLUSION Patients with a self-reported previous admission within 1 year may represent a high-risk group for colonization by methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci at hospital admission and should be considered for targeted active surveillance culturing.

[1]  D. Calfee,et al.  Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.

[3]  J. Bartlett Methicillin-resistant Staphylococcus aureus infections in correctional facilities---Georgia, California, and Texas, 2001-2003. , 2003, MMWR. Morbidity and mortality weekly report.

[4]  Y. Carmeli,et al.  Carriage of Methicillin-Resistant Staphylococcus Aureus at Hospital Admission , 1998, Infection Control & Hospital Epidemiology.

[5]  J. Jernigan,et al.  Prevalence of and Risk Factors for Colonization With Methicillin-Resistant Staphylococcus aureus in an Outpatient Clinic Population , 2003, Infection Control & Hospital Epidemiology.

[6]  T. Karchmer,et al.  Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. , 2002, The Journal of hospital infection.

[7]  M. Collins,et al.  Identification of Enterococcus species isolated from human infections by a conventional test scheme , 1989, Journal of clinical microbiology.

[8]  S. Ghosh,et al.  Prevalence of methicillin-resistant Staphylococcus aureus colonization in surgical patients, on admission to a Welsh hospital. , 2002, The Journal of hospital infection.

[9]  A. Harris,et al.  Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  D. Hospenthal,et al.  Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  C. Brun-Buisson,et al.  Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. , 1999, JAMA.

[12]  A. Harris,et al.  Risk Factors for Piperacillin-Tazobactam-Resistant Pseudomonas aeruginosa among Hospitalized Patients , 2002, Antimicrobial Agents and Chemotherapy.

[13]  Carlene A. Muto,et al.  SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus , 2003, Infection Control & Hospital Epidemiology.

[14]  J. Morris,et al.  Epidemiological Risk Factors for Isolation of Ceftriaxone-Resistant versus -Susceptible Citrobacter freundii in Hospitalized Patients , 2003, Antimicrobial Agents and Chemotherapy.

[15]  R. Venezia,et al.  Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission. , 2004, American journal of infection control.

[16]  Nnis System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.

[17]  Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. , 2001, MMWR. Morbidity and mortality weekly report.

[18]  Injury rates by industry 1970, BLS Report 406, Department of Labor, Bureau of Labor Statistics. , 1972, IMS, Industrial medicine and surgery.

[19]  M. Edmond Cost-Effectiveness of Perirectal Surveillance Cultures for Controlling Vancomycin-Resistant Enterococcus , 2003, Infection Control & Hospital Epidemiology.

[20]  Jessina C. McGregor,et al.  Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. , 2005, American journal of epidemiology.